Import Refusal Records
503,850 FDA import refusal records
| Date | Firm | Country | Product | Violations |
|---|---|---|---|---|
| 3/4/2025 | G.S. Kline Beacham Mississauga | CANADA | ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | SECUKINUMAB | 75UNAPPROVED |
| 3/4/2025 | ELIE PHARMACY Elie | CANADA | ADALIMUMAB | 75UNAPPROVED |
| 3/4/2025 | ELIE PHARMACY Elie | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Corporation East Hanover | UNITED STA | SECUKINUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | Rottendorf Pharma Gmbh Ennigerloh | GERMANY | EMPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 3/4/2025 | MSD PHARMACEUTICAL PVT LTD Bengaluru | INDIA | SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC) | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | Janssen Pharmaceuticals, Inc Titusville | UNITED STA | USTEKINUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | NOVO NORDISK Mississauga | CANADA | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | Janssen Inc. North York | CANADA | GUSELKUMAB | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | OMALIZUMAB | 75UNAPPROVED |
| 3/4/2025 | ELI LILLY CANADA INC Toronto | CANADA | IXEKIZUMAB | 75UNAPPROVED |
| 3/4/2025 | Bristol-Myers Squibb Montreal | CANADA | ABATACEPT | 75UNAPPROVED |
| 3/4/2025 | Sanofi-Aventis Deutschland GmbH Frankfurt Am Main | GERMANY | DUPILUMAB | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | SECUKINUMAB | 75UNAPPROVED |
| 3/4/2025 | Abbott Laboratories Abbott Park | UNITED STA | ADALIMUMAB | 75UNAPPROVED |
| 3/4/2025 | Janssen Pharmaceuticals, Inc Titusville | UNITED STA | USTEKINUMAB | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | SECUKINUMAB | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | OMALIZUMAB | 75UNAPPROVED |
| 3/4/2025 | Sanofi-Aventis Deutschland GmbH Frankfurt Am Main | GERMANY | DUPILUMAB | 75UNAPPROVED |
| 3/4/2025 | Novartis Pharmaceuticals Canada Inc. Dorval | CANADA | OMALIZUMAB | 75UNAPPROVED |
| 3/4/2025 | AbbVie Inc. North Chicago | UNITED STA | MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED |
| 3/4/2025 | Bristol-Myers Squibb Montreal | CANADA | METFORMIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 3/4/2025 | Glenmark Pharmaceuticals Limited Solan | INDIA | TELMISARTAN (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED |
| 3/4/2025 | Atlantic Animal Health, Inc. dba Squire Laboratories Revere | UNITED STA | NITROFURAZONE (ANTI-INFECTIVE, TOPICAL) | 75UNAPPROVED |
| 3/4/2025 | Ultra Laboratorios, S.A. de C.V. Guadalajara | MEXICO | SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED |
| 3/4/2025 | Baxter Corporation Mississauga | CANADA | POTASSIC SALINE (INJECTION) (REPLENISHER) | 75UNAPPROVED |
About This Page
This page displays 50 FDA import refusal records from 5 countries. Records on this page involve violations including 75 (UNAPPROVED). Each record links to detailed firm profiles with complete violation history and risk assessments.
Viewing page 647 of 10,077 • Showing records 32,301-32,350 of 503,850 total